Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan.
Tanaka A, Harada K, Ebinuma H, Komori A, Yokokawa J, Yoshizawa K, Abe M, Miyake Y, Kikuchi K, Ohira H, Zeniya M, Yamamoto K, Ishibashi H, Onji M, Nakanuma Y, Tsubouchi H, Takikawa H. Tanaka A, et al. Among authors: onji m. Hepatol Res. 2011 Sep;41(9):877-86. doi: 10.1111/j.1872-034X.2011.00844.x. Epub 2011 Aug 24. Hepatol Res. 2011. PMID: 21883738
Prognosis of autoimmune hepatitis showing acute presentation.
Yamamoto K, Miyake Y, Ohira H, Suzuki Y, Zeniya M, Onji M, Tsubouchi H; Intractable Liver and Biliary Diseases Study Group of Japan. Yamamoto K, et al. Among authors: onji m. Hepatol Res. 2013 Jun;43(6):630-8. doi: 10.1111/j.1872-034X.2012.01109.x. Epub 2012 Oct 22. Hepatol Res. 2013. PMID: 23088515
Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis.
Miyake Y, Yamamoto K, Matsushita H, Abe M, Takahashi A, Umemura T, Tanaka A, Nakamuta M, Nakamoto Y, Ueno Y, Saibara T, Takikawa H, Yoshizawa K, Ohira H, Zeniya M, Onji M, Tsubouchi H; Intractable Hepato-Biliary Disease Study Group of Japan. Miyake Y, et al. Among authors: onji m. Hepatol Res. 2014 Dec;44(13):1299-307. doi: 10.1111/hepr.12305. Epub 2014 Mar 6. Hepatol Res. 2014. PMID: 24506172
Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis.
Nakamura M, Kondo H, Tanaka A, Komori A, Ito M, Yamamoto K, Ohira H, Zeniya M, Hashimoto E, Honda M, Kaneko S, Ueno Y, Kikuchi K, Shimoda S, Harada K, Arai K, Miyake Y, Abe M, Taniai M, Saibara T, Sakisaka S, Takikawa H, Onji M, Tsubouchi H, Nakanuma Y, Ishibashi H. Nakamura M, et al. Among authors: onji m. Hepatol Res. 2015 Aug;45(8):846-55. doi: 10.1111/hepr.12423. Epub 2014 Dec 11. Hepatol Res. 2015. PMID: 25220608
Zinc and hepatitis B virus vaccination.
Abe M, Akbar SM, Onji M. Abe M, et al. Among authors: onji m. Hepatol Res. 2006 May;35(1):1-2. doi: 10.1016/j.hepres.2006.02.010. Hepatol Res. 2006. PMID: 16890177 No abstract available.
Engineering immune therapy against hepatitis B virus.
Akbar F, Yoshida O, Abe M, Hiasa Y, Onji M. Akbar F, et al. Among authors: onji m. Hepatol Res. 2007 Oct;37 Suppl 3:S351-6. doi: 10.1111/j.1872-034X.2007.00251.x. Hepatol Res. 2007. PMID: 17931186
473 results